May 1, 2026: Study Links Ozempic (Semaglutide), Other GLP-1s To Hair Loss Risk A systemic review of 24 studies found evidence that the use of certain GLP-1s, including semaglutide (Ozempic), may increase risk of hair loss in patients
There have been five studies of exercise and GLP-1, and four out of five of them found higher concentrations of total GLP-1 after high-intensity-interval-training and sprint-interval-training as well as moderate-intensity-continuous-training, with no apparent difference between high-intensity-interval and moderate-intensity-continuous
Here are a few top offenders to be mindful of or, if possible, avoid altogether: Highly Processed Foods: Frozen or prepackaged foods can spike your blood sugar, cause fatigue, and upset digestion
Ozempic and other GLP-1 receptor agonists have transformed the treatment of obesity
The key difference is that compounded medications are not FDA-approved as finished products, though the ingredient and manufacturing processes follow strict regulatory guidelines
Support GLP-1: Promote your body's GLP-1 production, reduce hunger and cravings and support healthy weight management with 3 clinically-studied plant ingredients
